EUVIMEDOpdag EUVIMED
Systematische ÜbersichtMetaanalyseLeitlinie

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies

Jennifer Robblee, Mia T Minen, Benjamin W Friedman, Miguel A Cortel-LeBlanc iD, Achelle Cortel-LeBlanc, Serena L Orr

Headache: The Journal of Head and Face Pain · 2026-01 · 66 (1) · 53-76

DOI: 10.1111/head.70016 ↗

At a glance

Systematische Übersicht in Headache: The Journal of Head and Face Pain, published online on 2025-12-01. Written by Jennifer Robblee and 5 co-authors. Institution: Department of Neurology, Lewis Headache Clinic, Barrow Neurological Institute, Dignity Health, Phoenix, Arizona, USA. Major MEDLINE topics: Emergency Service, Hospital, Migraine Disorders, Nerve Block. Cited 24 times so far (Crossref); 59 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To update the 2016 American Headache Society (AHS) guideline on parenteral pharmacologic therapies for the management of migraine attacks in the emergency department (ED).

Methods

We conducted a systematic review and meta‐analysis using the same methodology as the 2016 guideline. The original search strategy was repeated and expanded to include studies of nerve blocks and sphenopalatine ganglion (SPG) blocks. We searched Medline, Embase, Cochrane, clinicaltrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform through February 10, 2025. Eligible studies were randomized controlled trials (RCTs) involving adults diagnosed with migraine, treated in the ED with intravenous (IV), intramuscular (IM), subcutaneous (SC), or nerve block (including SPG block) interventions. Two reviewers independently screened titles/abstracts and full texts; a third reviewer resolved disagreements. Data were extracted using a standardized form and verified by a second reviewer. Risk of bias was assessed using the American Academy of Neurology (AAN) criteria. Where applicable, meta‐analyses were performed. Efficacy was categorized as highly likely, likely, or possibly effective or ineffective. Clinical recommendations were developed using the AAN guideline development process.

Results

The search identified 26 new RCTs evaluating 20 injectable treatments. Of these, 12 were rated class I (low risk of bias), 9 class II, and 4 class III. Prochlorperazine IV, dexketoprofen IV, sumatriptan SC, and greater occipital nerve blocks (GONB) were considered highly likely to be effective based on multiple class I studies. Chlorpromazine IV, metoclopramide IV, eptinezumab IV, ketorolac IV, and supraorbital nerve blocks (SONB) were considered likely effective based on one class I or multiple class II studies. Hydromorphone IV, propofol IV, and paracetamol IV were considered likely ineffective based on class I or multiple class II studies. After review of the evidence and a consensus process, recommendations were made for each intervention.

Conclusions

Prochlorperazine IV and GONB must be offered to eligible adults presenting to the ED with a migraine attack for treatment of headache requiring parenteral therapy (level A – must offer) in those without contraindications, while hydromorphone IV must not be offered (level A – must not offer). Treatments that should be offered when appropriate (level B – should offer) include dexketoprofen IV, ketorolac IV, metoclopramide IV, sumatriptan SC, and SONB. Chlorpromazine IV, dexamethasone IV, and valproate IV may be offered (level C – may offer). Paracetamol IV may not be offered (level C – should not offer). Eptinezumab should be offered (level B) only for patients matching the clinical trial population but is rated level U – no recommendation for an ED‐specific population. Additional evidence is needed for caffeine, granisetron, ibuprofen, ketamine, lidocaine, normal saline, propofol, and SPG blocks, all currently rated level U – no recommendation.

Subjects

MeSH terms (MEDLINE)

Emergency Service, HospitalMigraine DisordersNerve BlockAdultHumansRandomized Controlled Trials as TopicSocieties, Medical

Author keywords

acute migraineacute treatmentadultsemergency departmentparenteral pharmacotherapies

Authors and institutions

  • Department of Neurology, Lewis Headache Clinic, Barrow Neurological Institute, Dignity Health, Phoenix, Arizona, USA.
  • Department of Neurology, NYU Langone Health, New York, New York, USA.
  • Department of Population Health, NYU Langone Health, New York, New York, USA.
  • Department of Emergency Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Emergency Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.

ORCID profiles: Miguel A Cortel-LeBlanc

Cite

APA

Robblee, J., Minen, M. T., Friedman, B. W., Cortel-LeBlanc, M. A., Cortel-LeBlanc, A., & Orr, S. L. (2026). 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain, 66(1), 53-76. https://doi.org/10.1111/head.70016

Vancouver

Robblee J, Minen MT, Friedman BW, Cortel-LeBlanc MA, Cortel-LeBlanc A, Orr SL. 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain. 2026;66(1):53-76. doi:10.1111/head.70016

BibTeX
@article{Robblee2026,
  author = {Robblee, Jennifer and Minen, Mia T and Friedman, Benjamin W and Cortel-LeBlanc, Miguel A and Cortel-LeBlanc, Achelle and Orr, Serena L},
  title = {2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {1},
  pages = {53--76},
  doi = {10.1111/head.70016}
}
Start for free →